Literature DB >> 15764449

Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective.

Aparna Deshpande1, Ajit Menon, Matthew Perri, George Zinkhan.   

Abstract

The growth in direct-to-consumer advertising(DTCA)over the past two decades has facilitated the communication of prescription drug information directly to consumers. Data from a 1999 national survey are employed to determine the factors influencing consumers' opinions of the utility of DTC ads for health care decision making. We also analyze whether consumers use DTC ad information in health care decision making and who are the key drivers of such information utilization. The study results suggest that consumers have positive opinions of DTCA utility, varying across demographics and perceptions of certain advertisement features. Specifically, consumers value information about both risks and benefits, but the perception of risk information is more important in shaping opinions of ad utility than the perception of benefit information. Consumers still perceive, however that the quality of benefit information in DTC ads is better than that of risk information. Opinions about ad utility significantly influence whether information from DTC ads is used in health care decision making.

Mesh:

Year:  2004        PMID: 15764449     DOI: 10.1080/10810730490523197

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  14 in total

1.  Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

Authors:  Robert A Bell; Laramie D Taylor; Richard L Kravitz
Journal:  Patient Educ Couns       Date:  2010-02-21

Review 2.  Cancer-related direct-to-consumer advertising: a critical review.

Authors:  Emily Z Kontos; K Viswanath
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

3.  Parent Preferences and Experiences with Psychological Treatment: Results from a Direct-to- Consumer Survey using the Marketing Mix Framework.

Authors:  Sara J Becker; Sarah A Helseth; Hannah E Frank; Katherine Escobar; Brittany Weeks
Journal:  Prof Psychol Res Pr       Date:  2018-04

4.  Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.

Authors:  Jessica T DeFrank; Nancy D Berkman; Leila Kahwati; Katherine Cullen; Kathryn J Aikin; Helen W Sullivan
Journal:  Health Commun       Date:  2019-04-11

5.  Potential spillover educational effects of cancer-related direct-to-consumer advertising on cancer patients' increased information seeking behaviors: results from a cohort study.

Authors:  Andy S L Tan
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

6.  Research and Scholarly Methods: Implementation Science Studies.

Authors:  Grace M Kuo; Katy E Trinkley; Borsika Rabin
Journal:  J Am Coll Clin Pharm       Date:  2022-06-24

7.  Part I, patient perspective: activating patients to engage their providers in the use of evidence-based medicine: a qualitative evaluation of the VA Project to Implement Diuretics (VAPID).

Authors:  Stacey A Pilling; Monica B Williams; Rachel Horner Brackett; Ryan Gourley; Mark W Vander Weg; Alan J Christensen; Peter J Kaboli; Heather Schacht Reisinger
Journal:  Implement Sci       Date:  2010-03-18       Impact factor: 7.327

8.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.

Authors:  Dominick L Frosch; David Grande; Derjung M Tarn; Richard L Kravitz
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

9.  Measuring Exposure to Direct-to-Consumer Advertising-A Validation Study in the Context of Cancer-Related Treatment Advertising.

Authors:  Andy Sl Tan; Robert C Hornik
Journal:  Commun Methods Meas       Date:  2014-01-01

10.  Disease Information in Direct-to-Consumer Prescription Drug Print Ads.

Authors:  Kathryn J Aikin; Helen W Sullivan; Kevin R Betts
Journal:  J Health Commun       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.